Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Recursion Pharmaceuticals is a clinical-stage biotechnology company revolutionizing drug discovery and development. They leverage a unique, integrated platform known as the Recursion Operating System (OS), which combines advanced machine learning, artificial intelligence, and high-throughput automated wet-lab biology to generate, analyze, and interpret massive datasets. This approach allows Recursion to explore novel biology, identify potential drug candidates, and advance them through development with greater speed and efficiency. Their focus areas include rare diseases, oncology, and inflammation & immunology, aiming to bring transformative medicines to patients with unmet medical needs.
Serves as the central hub for research and development, data science, engineering, and corporate operations. It houses their advanced automated laboratories and computational infrastructure.
The headquarters, located in The Gateway in downtown Salt Lake City, is a state-of-the-art facility designed to foster collaboration and innovation. It features extensive wet lab space, high-throughput screening automation, and significant computational resources. The design emphasizes open workspaces and communal areas.
Recursion fosters a highly interdisciplinary and collaborative work culture, bringing together experts in biology, chemistry, data science, AI/ML, engineering, and drug development. The environment is described as fast-paced, innovative, and mission-driven, with a focus on solving complex biological problems.
The Salt Lake City headquarters is central to Recursion's identity and operations, symbolizing its commitment to integrating technology and biology. Its location leverages Utah's growing tech talent pool and supportive business environment.
Recursion's primary operations are centered in the United States (Salt Lake City, UT and Milpitas, CA) and Canada (Toronto, ON and Montreal, QC). While physical office locations are concentrated in North America, their research, collaborations, and clinical trials have a global reach. They actively partner with pharmaceutical companies and academic institutions worldwide, and their drug development programs involve clinical trial sites across multiple countries. Their data-driven approach and AI platform enable a global perspective on biological research and drug discovery.
41 S Rio Grande St
Salt Lake City
Utah
USA
Address: MaRS Centre, West Tower, 661 University Ave, Suite 465, Toronto, ON M5G 1M1, Canada
To tap into Canada's strong AI ecosystem and academic institutions, enhancing Recursion's computational drug discovery platform and building collaborations within the Canadian life sciences community.
Address: 6650 Rue Saint-Urbain #300, Montréal, QC H2S 3G9, Canada (Acquired Valence Discovery's office)
To integrate Valence Discovery's expertise and technology into the Recursion OS, bolstering its AI-first drug discovery efforts and leveraging Montreal's world-renowned AI research hub.
Address: Undisclosed specific address (often associated with acquired Cyclica assets/personnel)
To incorporate Cyclica's unique deep learning technologies and talent into Recursion's broader drug discovery engine, expanding capabilities in predicting how drug candidates interact with multiple protein targets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Recursion' leadership includes:
Recursion has been backed by several prominent investors over the years, including:
Recursion has seen significant executive team evolution in the past year, including a new CFO, a new CBO, an interim CMO, and the appointment of a Chief Commercial and Strategy Officer. These changes reflect the company's growth and strategic focus on advancing its pipeline and commercial readiness.
Discover the tools Recursion uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Recursion Pharmaceuticals commonly uses the 'first.last@recursion.com' email format. Variations might exist, but this is the most frequently observed pattern for professional communication.
first.last@recursion.com
Format
chris.gibson@recursion.com
Example
85%
Success rate
Recursion Press Release • 2024-05-29
Recursion appointed Theresa Heggie as its first Chief Commercial and Strategy Officer, effective June 10, 2024. Heggie brings over 25 years of experience in the biopharmaceutical industry, aiming to guide Recursion's commercial strategy as its pipeline matures....more
Recursion Press Release • 2024-05-08
Recursion reported its Q1 2024 financial results, highlighting progress in its clinical programs, advancements in its AI platform, and strategic collaborations, including with NVIDIA. The company also noted ongoing efforts to scale its drug discovery engine....more
Recursion Press Release • 2024-03-06
While announced earlier, the impact of acquiring Cyclica (assets and team) and Valence Discovery continues to be integrated. This strategic move significantly enhanced Recursion's AI capabilities in digital chemistry, generative AI, and machine learning for drug discovery....more
NVIDIA Blog • 2024-01-08
At the J.P. Morgan Healthcare Conference, Recursion's CEO discussed how the company is leveraging generative AI models, including its own proprietary models trained on NVIDIA DGX Cloud, to accelerate the discovery of new medicines. NVIDIA also announced an equity investment in Recursion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Recursion, are just a search away.